Alkabban FM, Ferguson T. Breast Cancer StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

Akram M, Iqbal M, Daniyal M, Khan AU. Awareness and current knowledge of breast cancer. Biol Res. 2017; 50(1): 1-23.

https://doi.org/10.1186/s40659-017-0140-9

PMid:28969709 PMCid:PMC5625777

Abo-Touk NA, Sakr HA, & Abd El-Lattef ATIF. Switching to letrozole versus continued tamoxifen therapy in treatment of postmenopausal women with early breast cancer. J Egypt Natl Canc Inst. 2010; 22(1): 79-85.

Geisler J, Sasano H, Chen S, Purohit A. Steroid sulfatase inhibitors: promising new tools for breast cancer therapy? J Steroid Biochem Mol Biol. 2011; 125(1-2): 39-45.

https://doi.org/10.1016/j.jsbmb.2011.02.002

PMid:21356310

AlFakeeh A, Brezden-Masley C. Overcoming endocrine resistance in hormone receptor-positive breast cancer. Curr Oncol. 2018; 25(s1): 18-27.

https://doi.org/10.3747/co.25.3752

PMid:29910644 PMCid:PMC6001756

Szostakowska M, Trębińska-Stryjewska A, Grzybowska EA, Fabisiewicz A. Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals. Breast Cancer Res Treat. 2019;173(3): 489-497.

https://doi.org/10.1007/s10549-018-5023-4

PMid:30382472 PMCid:PMC6394602

Moiseenko F, Volkov N, Bogdanov A, Dubina M, Moiseyenko V. Resistance mechanisms to drug therapy in breast cancer and other solid tumors. An opinion F1000Research. 2017;6:288.

https://doi.org/10.12688/f1000research.10992.1

PMid:28751966 PMCid:PMC5506585

Bachtiar M, Lee CG. Genetics of population differences in drug response. Curr Genet Med Rep. 2013; 1(3):162-170.

https://doi.org/10.1007/s40142-013-0017-3

Kharrati KH, Mohammadabadi MR, Tarang A, Kharrati KM, Esmailizadeh KA. Study of the association between the allelic variations in DGAT1 gene with mastitis in Iranian Holstein cattle. Modern genetic. 2012; 11(2): 14-23.

Koopaee HK, Koshkoiyeh AE. (2014) SNPs Genotyping technologies and their applications in farm animals breeding programs. Braz Arch Biol Technol. 2014; 57: 87-95.

https://doi.org/10.1590/S1516-89132014000100013

Madian AG, Wheeler HE, Jones RB, Dolan ME. (2012) Relating human genetic variation to variation in drug responses. Trends in Genetics. 2012; 28(10): 487-495.

https://doi.org/10.1016/j.tig.2012.06.008

PMid:22840197 PMCid:PMC3448823

Esfandiari P, Dadpasand M, Kharrati-Koopaee H, Atashi H, Gharghi A, Niazi A. Bioinformatics, phylogenetic and variant association analysis of Ovocalyxin-32 gene reveals its contribution to egg production traits in native chickens. Anim Gene. 2020; 17:200108.

https://doi.org/10.1016/j.angen.2020.200108

White IN, Smith LL. Mechanisms of Tamoxifen-Induced Genotoxicity and Carcinogenicity In Hormonal Carcinogenesis II. Springer, New York, NY. 1996;1: 228-239.

https://doi.org/10.1007/978-1-4612-2332-0_26

Brown K. Is tamoxifen a genotoxic carcinogen in women?. Mutagenesis. 2009 ;24(5):391-404.

https://doi.org/10.1093/mutage/gep022

PMid:19505894

Liapis E, McLuckie K, Lewis P, Farmer P, Brown K. Mutagenicity of tamoxifen induced DNA damage in human endometrial cells and in silico prediction of p53 mutation hotspots. Cancer Res. 2008;68(9): 5596-5596.

https://doi.org/10.1093/nar/gkn586

PMid:18805907 PMCid:PMC2566887

Emons G, Mustea A, Tempfer C. Tamoxifen and Endometrial Cancer: A Janus-Headed Drug. Cancers (Basel). 2020; 7:12(9):2535.

https://doi.org/10.3390/cancers12092535

PMid:32906618 PMCid:PMC7564212

Davies R, Oreffo VI, Martin EA, Festing MF, White IN, Smith LL, Styles JA. Tamoxifen causes gene mutations in the livers of lambda/lacI transgenic rats. Cancer research. 1997; 57(7):1288-1293.

Lorizio W, Wu AH, Beattie MS, Rugo H, Tchu S, Kerlikowske K, Ziv E. Clinical and biomarker predictors of side effects from tamoxifen. Breast Cancer Res Treat. 2012; 132(3):1107-18.

https://doi.org/10.1007/s10549-011-1893-4

PMid:22207277 PMCid:PMC3335925

Wardell SE, Norris JD, McDonnell DP. Breast Cancer: Targeting mutant estrogen receptors. Elife. 2019; 8: e44181.

https://doi.org/10.7554/eLife.44181

PMid:30648967 PMCid:PMC6335051

Pinto N, Dolan ME. Clinically relevant genetic variations in drug metabolizing enzymes. Curr Drug Metab. 2011; 12(5):487-97.

https://doi.org/10.2174/138920011795495321

PMid:21453273 PMCid:PMC3110519

Kharrati-Koopaee H, Ebrahimie E, Dadpasand M, Niazi A, Esmailizadeh A. Genomic analysis reveals variant association with high altitude adaptation in native chickens. Scientific Rep. 2019; 9(1): 1-22.

https://doi.org/10.1038/s41598-019-45661-7

PMid:31239472 PMCid:PMC6592930

Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008; 5(7): 621-628.

https://doi.org/10.1038/nmeth.1226

PMid:18516045

Doan R, Cohen ND, Sawyer J, Ghaffari N, Johnson CD, Dindot SV. Whole-genome sequencing and genetic variant analysis of a Quarter Horse mare. BMC genomics. 2012; 13(1):1-12.

https://doi.org/10.1186/1471-2164-13-78

PMid:22340285 PMCid:PMC3309927

Almansour NM. Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence. Front Mol Biosci. 2022 25; 9:836417.

https://doi.org/10.3389/fmolb.2022.836417

PMid:35145999 PMCid:PMC8824427

Wu Y, Qian Y, Zhou G, Lv J, Yan Q, Dong X. Effect of GEN1 interference on the chemosensitivity of the breast cancer MCF 7 and SKBR3 cell lines. Oncol lett. 2016; 11(6): 3597-3604.

https://doi.org/10.3892/ol.2016.4489

PMid:27284361 PMCid:PMC4887781

Turnbull C, Hines S, Renwick A, Hughes D, Pernet D, Elliott A, Rahman N. (2010) Mutation and association analysis of GEN1 in breast cancer susceptibility. Breast Cancer Res Treat. 2010; 124(1): 283-288.

https://doi.org/10.1007/s10549-010-0949-1

PMid:20512659 PMCid:PMC3632835

Sun L, Zhang Y, Pan Z, Li B, Sun M, Zhang X. (2014) Expression and Localization of GEN1 in Mouse Mammary Epithelial Cells. J Biochem Mol Toxicol. 2014; 28(10): 450-455.

https://doi.org/10.1002/jbt.21584

PMid:24980922

Chang YW, Tseng CF, Wang MY, Chang WC, Lee CC, Chen LT, Su JL. Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer. Oncogene. 2016; 35(12):1517-1528.

https://doi.org/10.1038/onc.2015.214

PMid:26119938

Zoppino FC, Guerrero-Gimenez ME, Castro GN, Ciocca DR. Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer. BMC cancer. 2018;18(1): 1-17.

https://doi.org/10.1186/s12885-018-4621-1

PMid:29954368 PMCid:PMC6022707

Pond KW, de Renty C, Yagle MK, Ellis NA. Rescue of collapsed replication forks is dependent on NSMCE2 to prevent mitotic DNA damage. PLoS Genet. 2019;15(2): e1007942.

https://doi.org/10.1371/journal.pgen.1007942

PMid:30735491 PMCid:PMC6383951

Jacome A, Gutierrez-Martinez P, Schiavoni F, Tenaglia E, Martinez P, Rodríguez-Acebes S, Fernandez-Capetillo O. NSMCE 2 suppresses cancer and aging in mice independently of its SUMO ligase activity. EMBO J. 2015; 34(21): 2604-2619.

https://doi.org/10.15252/embj.201591829

PMid:26443207 PMCid:PMC4641528

Cox DG, Hankinson SE, Hunter DJ. Polymorphisms of the AURKA (STK15/Aurora Kinase) gene and breast cancer risk (United States). Cancer Causes & Control. 2006; 17(1): 81-83.

https://doi.org/10.1007/s10552-005-0429-9

PMid:16411056

Staff S, Isola J, Jumppanen M, Tanner M. Aurora-A gene is frequently amplified in basal-like breast cancer. Oncol Rep. 2010; 23(2): 307-312.

https://doi.org/10.3892/or_00000637

Mahtab M, Boavida A, Santos D, Pisani FM. The Genome Stability Maintenance DNA Helicase DDX11 and Its Role in Cancer. Genes. 2021; 12(3): 395.

https://doi.org/10.3390/genes12030395

PMid:33802088 PMCid:PMC8000936

Tian J, Fan J, Xu J, Ren T, Guo H, Zhou L. circ FNTA accelerates proliferation and invasion of bladder cancer. Oncol lett. 2020; 19(1): 1017-1023.

https://doi.org/10.3892/ol.2019.11150

Masjedi A, Hashemi V, Hojjat-Farsangi M, Ghalamfarsa G, Azizi G, Yousefi M, Jadidi-Niaragh F. (2018) The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer. Biomed Pharmacother. 2018; 108:1415-24.

https://doi.org/10.1016/j.biopha.2018.09.177

PMid:30372844

Jia S, Zhang B, Liu J, Qin Y, Liang C, Shi S, Yu X. ALDOA functions as an oncogene in the highly metastatic pancreatic cancer. Cancer lett. 2016; 374(1): 127-135.

https://doi.org/10.1016/j.canlet.2016.01.054

PMid:26854714

Mathe A, Wong-Brown M, Morten B, Forbes JF, Braye SG, Avery-Kiejda KA, Scott RJ. (2015) Novel genes associated with lymph node metastasis in triple negative breast cancer. Scientific Rep. 2015; 5(1): 1-13.

https://doi.org/10.1038/srep15832

PMid:26537449 PMCid:PMC4633580

Gao SP, Sun HF, Fu WY, Li LD, Zhao Y, Chen MT, Jin W. High expression of COX5B is associated with poor prognosis in breast cancer. Future Oncology. 2017;13(19): 1711-1719.

https://doi.org/10.2217/fon-2017-0058

PMid:28592145